CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 4 Open-market buy CHAIRMAN AND CEO bought 1,356,990 shares at an average $0.02 ($23,537)
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- D Other Notice of Sales of Unregistered Securities
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 8-K Event Unregistered share sale · Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHAIRMAN AND CEO bought 240,000 shares at $0.04 ($10,344)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market buy CHAIRMAN AND CEO bought 255,000 shares at $0.05 ($11,475)
- 4 Open-market buy CFO bought 20,000 shares at $0.05 ($1,000)
- 4 Open-market buy CHAIRMAN AND CEO bought 335,759 shares at an average $0.04 ($15,013)
- 10-Q Report Quarterly Report
Page 1 of 61 · 1,218 filings